Up to 90% of women take medication at some stage during pregnancy and breastfeeding. Even though many of those medicines are safe to use, only 3,7% of them are explicitly labelled as safe. 1 in 3 choose to discontinue treatment, with potentially serious consequences to their health. With around 5,000,000 pregnancies in Europe ever year, the number of women who are affected is staggering. Of the available medicines, 71% include no information on use when pregnant, and 83% include no information on use when breastfeeding. Of the women, 25% experience anxiety due to a lack of information about medicines. 52% encounter inconsistencies in the available information, 40% report difficulty understanding what is available, and 20% cannot find any relevant information at all.

See references: https://www.imi-conception.eu/references/

The ConcePTION project: bridging the gap

Up to 90% of women take medication at some stage during pregnancy and breastfeeding. Even though many of those medicines are safe to use, only 3,7% of them are explicitly labelled as safe. 1 in 3 choose to discontinue treatment, with potentially serious consequences to their health. With around 5,000,000 pregnancies in Europe ever year, the number of women who are affected is staggering. Of the available medicines, 71% include no information on use when pregnant, and 83% include no information on use when breastfeeding. Of the women, 25% experience anxiety due to a lack of information about medicines. 52% encounter inconsistencies in the available information, 40% report difficulty understanding what is available, and 20% cannot find any relevant information at all. See references.

About ConcePTION

ConcePTION is a project funded by the Innovative Medicines Initiative, a private public partnership. The project was launched in April 2019.

We believe that we have an important societal obligation to radically and rapidly reduce uncertainty about the effects of medication used during pregnancy and breastfeeding to benefit women in making informed decisions about medications used before, during and after pregnancy.

Reporting medicine use in pregnancy

Did you use any medicines when you were pregnant? Here is how you and your health care provider can report what we call an exposure.

Ten principles for stakeholder engagement in the ConcePTION project

The ConcePTION project is building much-needed knowledge for women and health care professionals. To achieve our goal of building an ecosystem for medicine safety in pregnancy and breastfeeding, we need to engage with women, their partners, their doctors, pharmacists, midwives and nurses, the companies that develop medicines and the authorities that approve them and decide what becomes available to patients. Our goal is to work in an open and inclusive way, with the spirit of mutual respect and trust. Here is how we engage with stakeholders in an ethical way.

News

Nov
25
2024
Can we use real-world data to study medicine safety in pregnancy and lactation? Yes, we can! Join us on 11 December between 14:00-15:30 (CET) to learn more about our real-world data pipeline for pharmacoepidemiology studies and how you can use it for a range of research questions. | READ MORE >>
Nov
20
2024
At the end of 2024, the IMI ConcePTION consortium formally disbands after five years of progress to improve medicine safety in pregnancy and breastfeeding. On Thursday 21 November, we are hosting an event in Brussels to mark the end of the project, and plan for the future: presenting 10 proposals for policy that can improve access to accurate and reliable information about medicine safety in the coming ten years! | READ MORE >>
Nov
14
2024
Access to good quality data is essential for assessing medicine safety in pregnancy. The ConcePTION project has developed an app to collect information from expecting mothers in the United Kingdom. The Meds4Mums2B app will allow women in the United Kingdom to both report the medicines they use and receive information on medicine safety through the app. | READ MORE >>

The ConcePTION consortium

The project unites an unprecedented 88 organizations from 22 countries, including the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks to innovate new solutions to a decades-long public health issue.

OUR CONSORTIUM
»

The ConcePTION project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.